David Wagner, OD
Optometrist · Seneca, PANPI 1295754778
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,275 of the $7,149 with a category attached, or 73.8%. 21 manufacturers reported payments, led by Alcon at 24.8% of the total. Reporting peaked in 2022 at $2,023 and has fallen 59.3% since, to $824 in 2025. Among optometrist clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 194 payments — averaging $36.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$2K
- Johnson & Johnson Vision Care, Inc.$1K
- Sun Pharmaceutical Industries Inc.$862
- Bausch & Lomb Americas Inc.$677
- Tarsus Pharmaceuticals, Inc.$366
- LKC Technologies, Inc.$346
- plus $2K from 15 others
Across 94 payments — averaging $38.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Notal Vision, Inc.$4K
What the payments were for
- Consulting fees$250%
- Travel & lodging$1,77525%
- Food & beverage$5,27574%
- Entertainment$741%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 17 | $1,771 |
| Johnson & Johnson Vision Care, Inc. | 6 | $1,109 |
| Sun Pharmaceutical Industries Inc. | 64 | $862 |
| Bausch & Lomb Americas Inc. | 16 | $677 |
| Tarsus Pharmaceuticals, Inc. | 12 | $366 |
| LKC Technologies, Inc. | 5 | $346 |
| Coopervision Inc. | 9 | $321 |
| Novartis | 18 | $316 |
| Topcon Healthcare, Inc. | 3 | $230 |
| AbbVie(2 entities) | 11 | $206 |
| Biotissue Holdings Inc. | 4 | $191 |
| Dompe US, Inc. | 3 | $145 |
| Oyster Point Pharma, Inc. | 7 | $129 |
| Thea Pharma Inc. | 5 | $104 |
| Shire North American Group Inc | 5 | $94 |
| Optos, Inc. | 1 | $74 |
| Optovue, Inc. | 1 | $73 |
| Kala Pharmaceuticals, Inc. | 4 | $70 |
| Aerie Pharmaceuticals, Inc. | 1 | $25 |
| Harrow Eye, LLC | 1 | $24 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAILIES TOTAL1 Multifocal$1,218
- Dailies Aqua Comfort Plus$1,218
- AIR OPTIX$1,218
- Acuvue$1,004
- MIEBO$224
- Precision7$150
- Precision 1$141
- Prokera$137
- AmnioGraft$137
- XIIDRA$114
- XDEMVY$114
- VYZULTA$114
- Clariti Contact Lens$107
- CEQUA$106
- Oxervate$101
How this compares
$7,149 in reported general payments places this provider in the 95th percentile of 2,165 optometrist providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 134 | $186,890 |
| XiidraLifitegrast | 109 | $155,934 |
| XdemvyLotilaner | 38 | $68,712 |
| LumiganBimatoprost | 116 | $63,824 |
| Cyclosporine | 66 | $46,553 |
| RocklatanNetarsudil Mesylat/Latanoprost | 44 | $37,065 |
| CequaCyclosporine | 38 | $30,478 |
| IyuzehLatanoprost/Pf | 15 | $12,769 |
| CombiganBrimonidine Tartrate/Timolol | 22 | $7,067 |
| Loteprednol Etabonate | 25 | $4,593 |
| Travatan ZTravoprost | 11 | $3,287 |
| Timolol Maleate | 79 | $1,252 |
| Bimatoprost | 11 | $970 |
| Prednisolone Acetate | 14 | $964 |
| Latanoprost | 37 | $627 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan, Combigan | $206 | $257,781272 claims |
| Bausch & Lomb Americas Inc.Xiidra | $677 | $155,934109 claims |
| Tarsus Pharmaceuticals, Inc.Xdemvy | $366 | $68,71238 claims |
| Aerie Pharmaceuticals, Inc.Rocklatan | $25 | $37,06544 claims |
| Sun Pharmaceutical Industries Inc.Cequa | $862 | $30,47838 claims |
| Thea Pharma Inc.Iyuzeh | $104 | $12,76915 claims |
| Bausch & Lomb, A Division Of Bausch Health US, LLCLoteprednol Etabonate | $16 | $4,59325 claims |
| NovartisTravatan Z | $316 | $3,28711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,165 optometrist providers in Pennsylvania.
Other optometrist in Seneca
- James DeomHazle Township$793K
- Gregory CaldwellDuncansville$547K
- Leslie O DellNew Freedom$388K
- Kevin BistlinePlymouth Meeting$302K
- Thomas KislanStroudsburg$266K
- Erick HendersonPittsburgh$266K
- Ryan YealyLancaster$164K
- Joseph SmayNew Kensington$147K
- Julie McLaughlinAllentown$142K
- Robert RosenthalNewtown$127K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.